GL1X · GenesisL1 explorer

MolNFT v2 · #213888 · protein

Crystal structure of SARS-CoV2 N-NTD complexed with 5-Benzyloxygramine derivative (P3-8)

8J6X · Nucleoprotein: “Crystal structure of SARS-CoV2 N-NTD complexed with 5-Benzyloxygramine derivative (P3-8)”. X-ray diffraction at 2.7, 1 ligand (U2H), 1 pocket (best druggability 0.83). MolNFT v2 #213888 on GenesisL1: 3D structure…

PDB
8J6X
Type
protein
Length
508 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
2.7
Source
Severe acute respiratory syndrome coronavirus 2
Molecule
Nucleoprotein
UniProt
P0DTC9
Ligands
U2H
Pockets
1 · best druggability 0.83

Structure

x-ray diffraction · resolution 2.7 · 4 distinct chains · 1% helix, 25% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANucleoproteinprotein1262% helix, 25% strandP0DTC9
BNucleoproteinprotein1280% helix, 24% strandP0DTC9
CNucleoproteinprotein1272% helix, 24% strandP0DTC9
DNucleoproteinprotein1270% helix, 27% strandP0DTC9

Ligands and binding sites

  • U2H · ~{N}-methyl-~{N}-[(5-phenylmethoxy-1~{H}-indol-3-yl)methyl]propan-1-amine · ligand · chains A, B, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110910.830.84115U2H

Interfaces

5 interfaces between chains.

  • A–B · 537 Ų buried · 8 hydrogen bonds · protein-protein
  • A–C · 394 Ų buried · 2 hydrogen bonds · protein-protein
  • B–C · 349 Ų buried · 2 hydrogen bonds · protein-protein
  • A–D · 339 Ų buried · 6 hydrogen bonds · protein-protein
  • B–D · 176 Ų buried · 2 hydrogen bonds · protein-protein

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.